These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 33898689)

  • 1. Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors.
    Szabó Z; Szabó T; Bodó K; Kemenesi G; Földes F; Kristóf K; Barabás E; Vásárhelyi B; Prohászka Z; Fodor E; Jakab F; Berki T; Lacza Z
    Pract Lab Med; 2021 May; 25():e00222. PubMed ID: 33898689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the
    Pieri M; Infantino M; Manfredi M; Nuccetelli M; Grossi V; Lari B; Tomassetti F; Sarubbi S; Russo E; Amedei A; Benucci M; Casprini P; Stacchini L; Castilletti C; Bernardini S
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):74. PubMed ID: 35227017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
    Grenache DG; Ye C; Bradfute SB
    J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples.
    Ibrahim EH; Ghramh HA; Kilany M
    J King Saud Univ Sci; 2021 Jun; 33(4):101439. PubMed ID: 33879983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
    Walker GJ; Naing Z; Ospina Stella A; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test.
    Šimánek V; Pecen L; Krátká Z; Fürst T; Řezáčková H; Topolčan O; Fajfrlík K; Sedláček D; Šín R; Pazdiora P; Zelená H; Slouka D; Kučera R
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.
    Terpos E; Politou M; Sergentanis TN; Mentis A; Rosati M; Stellas D; Bear J; Hu X; Felber BK; Pappa V; Pagoni M; Grouzi E; Labropoulou S; Charitaki I; Ntanasis-Stathopoulos I; Moschandreou D; Bouhla A; Saridakis S; Korompoki E; Giatra C; Bagratuni T; Pefanis A; Papageorgiou S; Spyridonidis A; Antoniadou A; Kotanidou A; Syrigos K; Stamoulis K; Panayiotakopoulos G; Tsiodras S; Alexopoulos L; Dimopoulos MA; Pavlakis GN
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33260775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
    Ravichandran S; Coyle EM; Klenow L; Tang J; Grubbs G; Liu S; Wang T; Golding H; Khurana S
    Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32513867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19.
    Barrios MH; Nicholson S; Bull RA; Martinello M; Rawlinson W; Mina M; Post JJ; Hudson B; Gilroy N; Lloyd AR; Konecny P; Mordant F; Catton M; Subbarao K; Caly L; Druce J; Netter HJ
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD.
    Septisetyani EP; Prasetyaningrum PW; Anam K; Santoso A
    Immune Netw; 2021 Dec; 21(6):e39. PubMed ID: 35036026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of sample-to-cut-off ratio of anti-SARS-CoV-2 IgG antibody chemiluminescent assay with neutralization activity: a prospective multi-centric study in India.
    Tiwari AK; Negi G; Jaiswal RM; Aggarwal G; Yadav N; Kumar V; Kulathu K
    ISBT Sci Ser; 2021 Nov; 16(4):269-275. PubMed ID: 34548879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
    Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
    J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.
    Tan CW; Chia WN; Qin X; Liu P; Chen MI; Tiu C; Hu Z; Chen VC; Young BE; Sia WR; Tan YJ; Foo R; Yi Y; Lye DC; Anderson DE; Wang LF
    Nat Biotechnol; 2020 Sep; 38(9):1073-1078. PubMed ID: 32704169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.